MYH11 and acute myeloid leukemia: On the other hand, it was reported that GATA2 deficiency restricts cell proliferation in AML cells and delays leukemogenesis in Cbfb-Myh11 knock-in mice, supporting the notion that GATA2 is a poor prognostic marker in pediatric AML (22).